Roche Holding AG (RO)

Currency in CHF
339.40
+4.60(+1.37%)
Closed·
RO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
335.80339.80
52 wk Range
256.40383.00
Key Statistics
Bid/Ask
335.00 / 340.00
Prev. Close
334.8
Open
335.8
Day's Range
335.8-339.8
52 wk Range
256.4-383
Volume
24.74K
Average Volume (3m)
35.69K
1-Year Change
23.2389%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
367.00
Upside
+8.13%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Roche Holding AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 367.00
(+8.13% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
23/04/2026
EPS / Forecast
10.56 / --
Revenue / Forecast
14.72B / 15.19B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 16.04%
Dividend Yield
3.23%
Industry Median 2.44%
Annualised payout
10.80
Paid annually
5-Years Growth
+1.49%
Growth Streak

Compare RO to Peers and Sector

Metrics to compare
RO
Peers
Sector
Relationship
P/E Ratio
20.1x25.1x−0.5x
PEG Ratio
0.370.830.00
Price/Book
7.7x4.7x2.6x
Price / LTM Sales
4.1x4.6x3.1x
Upside (Analyst Target)
9.4%5.1%53.0%
Fair Value Upside
Unlock13.5%6.3%Unlock

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Employees
103249

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
89.24M11.22%29.88B
Other Institutional Investors
33.64M4.23%11.26B
Public Companies & Retail Investors
672.73M84.55%225.23B
Total
795.62M100.00%266.37B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Vanguard Group, Inc.4.26%33,930,60711,516,048
BlackRock, Inc.3.69%29,378,2159,970,966

People Also Watch

40.12
AXAF
+0.02%
37.09
UBSG
+0.03%
19.295
BBVA
+0.34%
292,500
005930
-2.34%

FAQ

What Is the Roche Holding (Switzerland: RO) Share Price Today?

The Roche Holding stock price today is 339.40 CHF.

What Stock Exchange Does Roche Holding (RO) Trade On?

Roche Holding is listed and trades on the Switzerland Stock Exchange.

What Is the Ticker (Stock Symbol) for Roche Holding?

The stock symbol (also called a 'ticker') for Roche Holding is "RO."

Does Roche Holding Pay Dividends? What’s The Current RO Dividend Yield?

Yes, RO Pays Dividends to its Shareholders. The current Roche Holding dividend yield is 3.23%.

What Is the Current Roche Holding Market Capitalisation?

As of today, Roche Holding (Switzerland: RO) market cap is 266.66B CHF.

What Is Roche Holding's (RO) Earnings Per Share (TTM)?

The Roche Holding EPS is currently 16.04 (Trailing Twelve Months).

When Is the Next Roche Holding Earnings Date?

Roche Holding's next earnings report will be released on 23/07/2026.

Is RO a Buy or Sell From a Technical Analyst Perspective?

Based on today's Roche Holding moving averages and other technical indicators, the daily buy/sell signal for RO stock is Strong Buy.

How Many Times Has Roche Holding Stock Split?

Roche Holding has split 1 times. (See the RO stock split history page for full effective split date and price information.)

How Many Employees Does Roche Holding Have?

Roche Holding has 103249 employees, based on their latest Companies House report.

What is the current trading status of Roche Holding (Switzerland: RO)?

As of 23/05/2026, Roche Holding (RO) is trading at a share price of 339.40 CHF, with a previous close of 334.80 CHF. The stock has fluctuated within a day range of 335.80 CHF to 339.80 CHF, while its 52-week range spans from 256.40 CHF to 383.00 CHF.

What Is Roche Holding (RO) Price Target According to Analysts?

The average 12-month price target for Roche Holding is 367.00 CHF, with a high estimate of 396 CHF and a low estimate of 340 CHF. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +8.13% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.